| Symbol | ASBPW |
|---|---|
| Name | ASPIRE BIOPHARMA HOLDINGS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 23150 FASHION DRIVE,SUITE 232, ESTERO, 33928, Puerto Rico |
| Telephone | +1 415 - 592-7399 |
| Fax | — |
| — | |
| Website | https://www.aspirebiolabs.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001847345 |
| Description | Aspire Biopharma is developing next generation absorption of medicine that will have a significant impact on the opioid crisis. Our nano technology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract. Aspires technology comes from a new mechanism of action (absorption pathway) which allows for instant absorption in the mouth. Benefits of "instant absorption" are to provide nearly instant treatment impact and also allows high dose absorption. Our technology can be applied to any number of proven drugs and supplements, such as analgesics, erectile dysfunction, and traumatic brain injury drugs. Additional info from NASDAQ: |
(99% Neutral) ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) Announces Business Combination
Read moreNew Form SCHEDULE 13G - Aspire Biopharma Holdings, Inc. <b>Filed:</b> 2026-07-02 <b>AccNo:</b> 0002142929-26-000001 <b>Size:</b> 7 KB
Read more(99% Neutral) ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) Announces Business Combination
Read more(99% Neutral) ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) Provides Business Update
Read more(19% Negative) ASPIRE BIOPHARMA HOLDINGS, INC. (ASBPW) Reports Q2 2026 Financial Results
Read moreNew Form SCHEDULE 13G - Aspire Biopharma Holdings, Inc. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0000919574-26-003204 <b>Size:</b> 9 KB
Read moreNew Form SCHEDULE 13G/A - Aspire Biopharma Holdings, Inc. <b>Filed:</b> 2026-05-13 <b>AccNo:</b> 0001213900-26-055622 <b>Size:</b> 34 KB
Read moreNew Form DEFR14A - Aspire Biopharma Holdings, Inc. <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001493152-26-022511 <b>Size:</b> 956 KB
Read moreNew Form DEF 14A - Aspire Biopharma Holdings, Inc. <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001493152-26-022026 <b>Size:</b> 1 MB
Read moreNew Form PRE 14A - Aspire Biopharma Holdings, Inc. <b>Filed:</b> 2026-04-27 <b>AccNo:</b> 0001493152-26-019171 <b>Size:</b> 330 KB
Read more